Literature DB >> 16116120

Prevalence and patterns of cognitive impairment in sporadic ALS.

G M Ringholz1, S H Appel, M Bradshaw, N A Cooke, D M Mosnik, P E Schulz.   

Abstract

OBJECTIVE: To investigate the prevalence and nature of cognitive changes associated with sporadic amyotrophic lateral sclerosis (ALS) using a large scale study.
METHODS: Consecutive patients with sporadic ALS (n = 279) underwent comprehensive neurologic evaluation and neuropsychological testing. Testing data from normal controls (n = 129) were used for classification and comparison purposes.
RESULTS: On non-motor, non-speed-dependent tasks, 51% of patients with ALS had evidence of cognitive impairment compared to 5% of controls. Cluster analysis suggested four patient subgroups: 49% intact, 32% with mild impairment, 13% with moderate impairment, and 6% with severe impairment. Forty-one patients (15%) met criteria for frontotemporal dementia (FTD). ALS patient subgroups, excluding the intact group, performed significantly lower on tests of executive function and memory than normal controls. Patients with more severe disease also had deficits in confrontation naming. Although memory function declined with increasing severity of overall cognitive impairment, only two patients had the severe memory loss typical of Alzheimer disease. Cognitive impairment was correlated with clinical measures of word-finding, phrase length, and motor programming. Cognitive impairment was not correlated with depression scores or severity or duration of motor or bulbar symptoms. Patients with bulbar vs limb-onset ALS were not different in either level of impairment or pattern of performance.
CONCLUSIONS: These data confirm the presence of cognitive impairment in 50% of patients with ALS and particularly implicate executive dysfunction and mild memory decline in the disease process. More severe impairment occurs in a subset of patients with ALS and has features consistent with FTD.

Entities:  

Mesh:

Year:  2005        PMID: 16116120     DOI: 10.1212/01.wnl.0000172911.39167.b6

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  224 in total

1.  Familial frontotemporal dementia with amyotrophic lateral sclerosis and a shared haplotype on chromosome 9p.

Authors:  Justin P Pearson; Nigel M Williams; Elisa Majounie; Adrian Waite; Jennifer Stott; Victoria Newsway; Alex Murray; Dena Hernandez; Rita Guerreiro; Andrew B Singleton; James Neal; Huw R Morris
Journal:  J Neurol       Date:  2010-11-12       Impact factor: 4.849

2.  Informed Consent in Implantable BCI Research: Identifying Risks and Exploring Meaning.

Authors:  Eran Klein
Journal:  Sci Eng Ethics       Date:  2015-10-23       Impact factor: 3.525

3.  Diffusion tensor imaging of basal ganglia and thalamus in amyotrophic lateral sclerosis.

Authors:  Khema R Sharma; Sulaiman Sheriff; Andrew Maudsley; Varan Govind
Journal:  J Neuroimaging       Date:  2012-01-24       Impact factor: 2.486

4.  Diffusion tensor tract-specific analysis of the uncinate fasciculus in patients with amyotrophic lateral sclerosis.

Authors:  Kanako Sato; Shigeki Aoki; Nobue K Iwata; Yoshitaka Masutani; Takeyuki Watadani; Yasuhiro Nakata; Mariko Yoshida; Yasuo Terao; Osamu Abe; Kuni Ohtomo; Shoji Tsuji
Journal:  Neuroradiology       Date:  2010-02-20       Impact factor: 2.804

5.  Predictors of emergent feeding tubes and tracheostomies in amyotrophic lateral sclerosis (ALS).

Authors:  Amy Y Tsou; Jason Karlawish; Leo McCluskey; Sharon X Xie; Judith A Long
Journal:  Amyotroph Lateral Scler       Date:  2012-05

6.  Deficits in sentence expression in amyotrophic lateral sclerosis.

Authors:  Sharon Ash; Christopher Olm; Corey T McMillan; Ashley Boller; David J Irwin; Leo McCluskey; Lauren Elman; Murray Grossman
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2014-12-08       Impact factor: 4.092

7.  Structural explanation of poor prognosis of amyotrophic lateral sclerosis in the non-demented state.

Authors:  H-J Kim; S-I Oh; M de Leon; X Wang; K-W Oh; J-S Park; A Deshpande; M Buj; S H Kim
Journal:  Eur J Neurol       Date:  2016-10-18       Impact factor: 6.089

8.  Survival profiles of patients with frontotemporal dementia and motor neuron disease.

Authors:  William T Hu; Harro Seelaar; Keith A Josephs; David S Knopman; Bradley F Boeve; Eric J Sorenson; Leo McCluskey; Lauren Elman; Helenius J Schelhaas; Joseph E Parisi; Benno Kuesters; Virginia M-Y Lee; John Q Trojanowski; Ronald C Petersen; John C van Swieten; Murray Grossman
Journal:  Arch Neurol       Date:  2009-11

Review 9.  Amyotrophic Lateral Sclerosis: Current Status in Diagnostic Biomarkers.

Authors:  Katerina Kadena; Panayiotis Vlamos
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

10.  Clinical and neuroimaging investigations of language disturbance in frontotemporal dementia-motor neuron disease patients.

Authors:  Zhe Long; Muireann Irish; Olivier Piguet; Matthew C Kiernan; John R Hodges; James R Burrell
Journal:  J Neurol       Date:  2019-02-01       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.